Stocklytics score rationale: value 70, quality 43, growth 66.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
3647047000
3300184000
3666812000
3327458000
1120700000
1426188000
1563101000
1707197000
2107623000
2248049000
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with…
Forecast
Consensus Buy from 15 analysts. Average price target $36.33, +62.2% versus the current price. Low $27.00. High $45.00.
Analysts have an average 12-month price target of $36.33 for Enovis (ENOV), 61.6% above the current price of $22.48. Of 15 analysts covering the stock, 12 rate it Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
ENOV price target
12-month price target
Low
$27.00
Average
$36.33
High
$45.00
The average is 61.6% above the current price of $22.48.
Is Enovis a buy or sell?
Of 15 analysts, 12 rate Enovis Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
The Stocklytics Score for ENOV is 60 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
ENOV forecast FAQs
What is the ENOV price target?
$36.33 average, with a published range of $27.00 to $45.00.
Is Enovis a buy or sell?
The consensus is Buy from 15 analysts. This is not a recommendation.
What is the Enovis stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $3.63. The average revenue estimate is $2.34 billion.
What will ENOV be worth in 2030?
No reliable forecast exists that far out.
When is Enovis's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.